生命科学资讯

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Lilly was the only pharma bidder for Ventyx

Insurance CEOs defend their businesses at House hearing

Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO

High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’

Drugmakers spent less on Washington lobbying in 2025's final quarter

Corcept's drug extends patients' lives in key ovarian cancer study

China-founded pharma Corxel raises up to $287M for oral GLP-1

Health insurance CEOs head to DC

Roche boosts NC factory investment to $2B; Rentschler CEO steps down

Another biopharma tried buying Amicus before BioMarin's $4.8B deal

Bristol Myers signs deal with Janux on T cell engager for $50M upfront

Erasca, Corvus, BioAge target $500M+ offerings

The status of EU drug price talks depends on who you ask

J&J praises new FDA guidance to speed development of multiple myeloma drugs

Johnson & Johnson brushes off MFN impact, sees strong growth for 2026

Tanabe pill delays blood disorder; enGene adds up to $100M from loans

IntraBio says rare disease drug passes Phase 3, will seek FDA approval

#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targets

Exclusive: Claim Health raises $4.4M to help home care providers get paid